Delivery Order SPE2DB22D2007-SPE2DB25FH9ZK
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ezetimibe 10 mg tablets. The contract has a ceiling value of $1,740.35 and a period of performance through November 13, 2024. It is a Firm Fixed Price contract type. This delivery order is placed against a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of EZETIMIBE 10 MG TABLET 500S. The contract has a firm fixed price of $2,718.04 and a period of performance through July 18, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,142.40 for the supply of 4567794734 EZETIMIBE 10 MG TABLET 500S, a pharmaceutical product. The contract has an ultimate completion date of April 4, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ezetimibe 10 mg tablets. The $8,313.85 firm fixed-price contract has a performance period through May 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,159.12 firm fixed-price contract is for the delivery of 4,566,670,756 tablets of the prescription drug ezetimibe 10 mg. The contract has a completion date of December 11, 2024 and does not utilize any set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ezetimibe 10 mg tablets in quantities of 500 units. This contract, valued at $3,910.92, represents a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The work is to be completed by September 19, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,346.31 Firm Fixed Price delivery order is for the supply of Ezetimibe 10 mg tablets. The contract is not set aside for any specific business type. It is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025, which enables the agency to efficiently...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,356.71, is for the delivery of 500 tablets of the pharmaceutical product Ezetimibe 10 mg. It is a firm fixed-price contract with a completion date of February 13, 2023. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $1,196.15 firm-fixed-price delivery order is for the supply of 4,565,243,581 units of the drug ezetimibe 10 mg tablets. There is no set-aside designation for this contract, which has an ultimate completion date of July 25, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a $2,269.98 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) for the supply of 4564804826 - Ezetimibe 10 mg Tablet 90s. The award has a completion date of June 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FH9ZKDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ezetimibe 10 mg tablets, a prescription medication, with a ceiling value of $1,146.21 and a performance period through March 2025. The contract is a delivery order, with a firm fixed price pricing type. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order award falls under that larger IDC contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 3/18/25 |